Implementation of new imported immunoglobulin supply arrangements
In December 2020, the National Blood Authority (NBA) finalised a procurement process for new national contracts for the supply of imported immunoglobulin (Ig) p
19 May 2022
Transition of Australia's domestic plasma products
19 May 2022
National supply arrangements for Hemlibra (emicizumab)
On 2 November 2020, Hemlibra became available under national supply arrangements.
02 Nov 2020
Update for IG Criteria: Neurology
We developed the Criteria for the clinical use of immunoglobulin in Australia (the Criteria) using specialist working groups of expert clinicians to identify th
01 Mar 2020